A!maginostic is an A*STAR IMCB spin-off company established in 2017. We are committed to advance quantitative digital pathology image analysis and reliable diagnostic solutions in both academic research and clinical application. The core technology team has extensive experience of designing and prototyping accurate, efficient and powerful solutions for cellular and digital pathology imaging informatics.
We integrate methodologies from multiple fields such as signal processing, image processing and computer vision, optimization, machine learning, pattern recognition, mathematical modeling, artificial intelligence (AI), deep learning (DL), in collaboration with pathologists, oncology Scientists and cell biologists, etc. Our goal is to provide patients/clinicians with efficient, accurate and robust digital pathology algorithms/solutions and improve healthcare for the public.
A!maginostic and A * STAR's Institute of Molecular and Cell Biology (IMCB) have established a joint laboratory of excellence in 2019. The collaboration will use image processing and artificial intelligence / machine learning to revolutionize pathology practices and provide more accurate cancer diagnostic assays.